Utah Builds National Blueprint for Healthcare AI Oversight as Sandbox Adds Prescription and Dermatology Pilots
The state's first-in-nation regulatory framework now includes independent evaluators and physician-led oversight, positioning Utah as the testing ground for balancing AI innovation with patient safety.
Utah is cementing its position as the nation's proving ground for healthcare AI regulation, expanding its pioneering regulatory sandbox with new clinical pilots and establishing a rigorous oversight infrastructure that could shape how artificial intelligence enters medical practice nationwide.
The state's Office of Artificial Intelligence Policy (OAIP) announced the addition of three healthcare AI companies to its sandbox program: August AI for prescription renewals, Nolla Health for dermatology consultations, and Expect Fitness for pelvic floor physical therapy. The expansion comes with a critical governance upgrade—six independent third-party evaluators will now audit AI systems, while a physician-led working group from the Utah Medical Licensing Board provides clinical oversight.
From Concerns to Comprehensive Oversight
The enhanced structure addresses earlier pushback from Utah's Medical Licensing Board, which had raised concerns about insufficient clinical oversight when the sandbox launched. The board has now established a physician working group that will evaluate pilots, set evidentiary standards, and provide ongoing supervision in coordination with OAIP.
The sandbox creates a structured pathway for health systems to deploy AI tools in clinical workflows with regulatory clarity, particularly for tasks requiring state licensure.
August AI's pilot covers up to 148 medications across 76 chronic conditions—96 at launch—including diabetes, hypertension, asthma, COPD, and thyroid disease. The service charges $4 per prescription renewal, with a Utah-licensed physician reviewing every renewal before authorization. Nolla Health's dermatology service costs $4.99 monthly for initial acne prescriptions through its Nolla Derm app, using five-angle face scans. The company reports clinicians agree with AI treatment recommendations in more than 96% of real-world cases.
Independent Validation Becomes Mandatory
The six third-party evaluators—Coalition for Health AI (CHAI), Clarion AI Partners, Glacis Technologies, mpathic AI, Vega Health, and Stanford Clinical Excellence Research Center—represent a significant shift toward independent validation rather than company self-reporting.
Companies must now demonstrate performance through independent evaluators, not just internal claims. Dr. Nirav Shah, a senior scholar at Stanford Clinical Excellence Research Center, and Dr. William Hamilton, an anesthesiologist on the Utah Medical Licensing Board, are among the clinical experts involved in oversight.
The sandbox has also established "umbrella agreements" with University of Utah Health and Intermountain Health for future AI pilot approvals. Intermountain Health alone reports 300 AI initiatives currently underway, mostly focused on administrative functions. Dan Liljenquist, Intermountain's Chief Strategy Officer, indicated major health systems are actively seeking AI solutions to address staffing constraints while maintaining clinical oversight requirements.
A Template for National Regulation
Utah's model creates a stage-gated approval process with clear liability and insurance expectations, offering AI developers a defined regulatory pathway while protecting patients through explicit disclosure requirements when AI is involved in care decisions. The program's multi-phase safety checks and continuous data auditing aim to balance innovation with patient protection.
The expansion follows the January 2025 announcement of Doctronic as the sandbox's first healthcare AI pilot for prescription renewals. With direct-to-consumer AI clinical services now entering the market at $4-$5 price points, Utah's framework may establish both the governance structure and economic benchmarks that shape healthcare AI deployment across the United States.
As states and federal agencies grapple with how to regulate AI in medicine, Utah's combination of physician oversight, independent evaluation, and structured pilot programs offers a practical model that other jurisdictions are likely watching closely.
Sources
Companies in this article
Reporting & accountability
How we maintain accuracy
Health AI Central separates reported facts, analysis, and public-source data. Readers can review our standards, request a correction, or consult the relevant research methodology before relying on a claim.